Novel Inflammatory Prognostic Markers in Lung Cancer Patients Treated with Definitive Chemoradiotherapy
Primary lung cancer is the most common cancer worldwide and is an increasingly common problem. The primary endpoint of this study was; to investigate the effect of radiotherapy dose and neutrophil-lymphocyte ratio (NLR) on overall survival (OS) and progression-free survival (PFS). We retrospectively...
Saved in:
| Main Authors: | Hakan Harputluoglu, Alper Yeniçeri, Ahmet Gulmez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Selcuk University Press
2022-12-01
|
| Series: | Genel Tıp Dergisi |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/tr/download/article-file/2391896 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Elderly Patients With Younger Age Patients Who Were Diagnosed With Non-Small Cell Lung Cancer in Terms of Operability
by: Aykut Eliçora, et al.
Published: (2019-08-01) -
Akciğerin Sarkomatoid Karsinomlarının Klinik ve Radyometabolik Özellikleri
by: Sevda Şener Cömert, et al.
Published: (2019-09-01) -
The Importance of the De Ritis Ratio and Glasgow Prognostic Score in prehypertensive patients
by: Ozge Ozcan Abacıoglu, et al.
Published: (2021-12-01) -
The Effects Of Tumor Localization On Small Cell Lung Cancer And Its Association With Prognosis
by: Sertan Bulut, et al.
Published: (2022-03-01) -
A CT-based subregional radiomics nomogram for predicting local recurrence-free survival in esophageal squamous cell cancer patients treated by definitive chemoradiotherapy: a multicenter study
by: Jie Gong, et al.
Published: (2024-12-01)